Key result
Hypertrophic cardiomyopathy presents with a complex spectrum of phenotypes, making its diagnosis, management, and prevention of sudden cardiac death a significant challenge for cardiologists.
The heterogeneity of hypertrophic cardiomyopathy phenotypes and symptoms presents a significant challenge for diagnosis and management.
Supports phenotype-specific HCM approaches; leaves open need for prospective validation before practice change.
The clinical spectrum of hypertrophic cardiomyopathy (HCM) is complex and includes a variety of phenotypes, which leads to different types of manifestations.Although most of the patients are asymptomatic, a significant proportion of them will develop symptoms or risk of arrhythmias and sudden cardiac death (SCD).Therefore, the objectives of HCM diagnosis and management are to relieve the patients' symptoms (chest pain, heart failure, syncope, palpitations, etc.), prevent disease progression and major cardiovascular complications and SCD.The heterogeneity of HCM patterns, their symptoms and assessment is a challenge for the cardiologist.
No takes yet. Share an insight, caveat, or question.
A 2015 study conducted a review in Hypertrophic cardiomyopathy (HCM). Hypertrophic cardiomyopathy presents with a complex spectrum of phenotypes, making its diagnosis, management, and prevention of sudden cardiac death a significant challenge for cardiologists.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: